Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Objective: Progranulin-related frontotemporal dementia (FTD-GRN) is a fast progressive disease. Modelling the cascade of multimodal biomarker changes aids in understanding the aetiology of this disease and enables monitoring of individual mutation carriers. In this cross-sectional study, we estimated the temporal cascade of biomarker changes for FTD-GRN, in a data-driven way. Methods: We included 56 presymptomatic and 35 symptomatic GRN mutation carriers, and 35 healthy non-carriers. Selected biomarkers were neurofilament light chain (NfL), grey matter volume, white matter microstructure and cognitive domains. We used discriminative event-based modelling to infer the cascade of biomarker changes in FTD-GRN and estimated individual disease severity through cross-validation. We derived the biomarker cascades in non-fluent variant primary progressive aphasia (nfvPPA) and behavioural variant FTD (bvFTD) to understand the differences between these phenotypes. Results: Language functioning and NfL were the earliest abnormal biomarkers in FTD-GRN. White matter tracts were affected before grey matter volume, and the left hemisphere degenerated before the right. Based on individual disease severities, presymptomatic carriers could be delineated from symptomatic carriers with a sensitivity of 100% and specificity of 96.1%. The estimated disease severity strongly correlated with functional severity in nfvPPA, but not in bvFTD. In addition, the biomarker cascade in bvFTD showed more uncertainty than nfvPPA. Conclusion: Degeneration of axons and language deficits are indicated to be the earliest biomarkers in FTD-GRN, with bvFTD being more heterogeneous in disease progression than nfvPPA. Our data-driven model could help identify presymptomatic GRN mutation carriers at risk of conversion to the clinical stage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Clinical, genetic and pathological heterogeneity of frontotemporal dementia: A review
Seelaar, H., Rohrer, J. D., Pijnenburg, Y. A. L., Fox, N. C., & van Swieten, J. C. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.212225 · Cited by 609
Self-citationYoung, A. L., Marinescu, R. V., Oxtoby, N. P., Bocchetta, M., Yong, K., Firth, N. C., Cash, D. M., Thomas, D. L., Dick, K. M., Cardoso, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05892-0 · Cited by 596
Self-citationRohrer, J. D., Nicholas, J. M., Cash, D. M., van Swieten, J., Dopper, E., Jiskoot, L., van Minkelen, R., Rombouts, S. A., Cardoso, M. J., Clegg, S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70324-2 · Cited by 538
Self-citationDevelopment of methodology for conducting clinical trials in frontotemporal lobar degeneration
Knopman, D. S., Kramer, J. H., Boeve, B. F., Caselli, R. J., Graff-Radford, N. R., Mendez, M. F., Miller, B. L., & Mercaldo, N. (2008) · Brain · doi:10.1093/brain/awn234 · Cited by 442
Clinical staging and disease progression in frontotemporal dementia
Mioshi, E., Hsieh, S., Savage, S., Hornberger, M., & Hodges, J. R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e04070 · Cited by 362
Neurofilament light chain: a biomarker for genetic frontotemporal dementia
Meeter, L. H., Dopper, E. G., Jiskoot, L. C., Sanchez‐Valle, R., Graff, C., Benussi, L., Ghidoni, R., Pijnenburg, Y. A., Borroni, B., Galimberti, D., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.325 · Cited by 263 · cited 1×
“biomarkers were: serum NfL [1-3], MMSE [4-6], cognitive domains of language, attention and”
Self-citationPatterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study
Cash, D. M., Bocchetta, M., Thomas, D. L., Dick, K. M., van Swieten, J. C., Borroni, B., Galimberti, D., Masellis, M., Tartaglia, M. C., Rowe, J. B., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.008 · Cited by 200
Self-citationEstimating long‐term multivariate progression from short‐term data
Donohue, M. C., Jacqmin‐Gadda, H., Le Goff, M., Thomas, R. G., Raman, R., Gamst, A. C., Beckett, L. A., Jack, C. R., Weiner, M. W., Dartigues, J., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.10.003 · Cited by 197
van der Ende, E. L., Meeter, L. H., Poos, J. M., Panman, J. L., Jiskoot, L. C., Dopper, E. G. P., Papma, J. M., de Jong, F. J., Verberk, I. M. W., Teunissen, C., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30354-0 · Cited by 181
Self-citation
Research works printed but not linked: 29
- 10.1016/S1474-4422(08)70194-7 · DOI · Paper page
- Mann, 2017, Frontotemporal lobar degeneration: pathogenesis, pathology and pathways to phenotype, Brain Pathol, 27, 723, 10.1111/bpa.12486 · DOI · Paper page
- Woollacott, 2016, The clinical spectrum of sporadic and familial forms of frontotemporal dementia, J Neurochem, 138 Suppl 1, 6, 10.1111/jnc.13654 · DOI · Paper page
- 10.1093/brain/awy288 · DOI · Paper page
- 10.1007/s00415-018-8850-7 · DOI · Paper page
- Venkatraghavan V , Bron EE , Niessen WJ . A discriminative event based model for Alzheimer’s disease progression modelling. Information Processing in Medical Imaging 2017:121–33. · DOI
- 10.1016/j.neuroimage.2012.01.062 · DOI · Paper page
- Venkatraghavan, 2019, Disease progression timeline estimation for Alzheimer's disease using discriminative event based modeling, Neuroimage, 186, 518, 10.1016/j.neuroimage.2018.11.024 · DOI · Paper page
- 10.1093/brain/awr179 · DOI · Paper page
- 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
- Parmera, 2016, Corticobasal syndrome: a diagnostic conundrum, Dement Neuropsychol, 10, 267, 10.1590/s1980-5764-2016dn1004003 · DOI
- Panman, 2019, Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study, Neurobiol Aging, 76, 115, 10.1016/j.neurobiolaging.2018.12.017 · DOI · Paper page
- 10.1212/WNL.44.12.2308 · DOI · Paper page
- 10.1017/S1355617718000735 · DOI
- 10.1002/acn3.601 · DOI · Paper page
- 10.1016/j.neuroimage.2011.09.015 · DOI · Paper page
- 10.1002/hbm.460030304 · DOI · Paper page
- Mori S , Wakana S , van Zijl PCM . MRI atlas of Human White Matter. Amsterdam, the Netherlands: Elsevier, 2005.
- Menke, 2015, Csf neurofilament light chain reflects corticospinal tract degeneration in ALS, Ann Clin Transl Neurol, 2, 748, 10.1002/acn3.212 · DOI · Paper page
- 10.1111/ggi.12661 · DOI
- Hase, 2018, White matter degeneration in vascular and other ageing-related dementias, J Neurochem, 144, 617, 10.1111/jnc.14271 · DOI · Paper page
- 10.3233/JAD-150806 · DOI · Paper page
- Mesulam, 2016, Primary progressive aphasia and the left hemisphere language network, Dement Neurocogn Disord, 15, 93, 10.12779/dnd.2016.15.4.93 · DOI
- 10.1016/S1474-4422(12)70099-6 · DOI · Paper page
- 10.3109/09540261.2013.778822 · DOI · Paper page
- Sudre, 2017, White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort, Neuroimage Clin, 15, 171, 10.1016/j.nicl.2017.04.015 · DOI · Paper page
- Lee, 2019, Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers, Neuroimage Clin, 22, 10.1016/j.nicl.2019.101751 · DOI · Paper page
- Benussi, 2019, Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia, Neurobiol Aging, 76, 133, 10.1016/j.neurobiolaging.2018.12.018 · DOI · Paper page
- Bonvicini, 2014, Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation, Neurobiol Aging, 35, 1206, 10.1016/j.neurobiolaging.2013.10.097 · DOI
Cited by
Frontotemporal lobar degeneration
Grossman, M., Seeley, W. W., Boxer, A. L., Hillis, A. E., Knopman, D. S., Ljubenov, P. A., Miller, B., Piguet, O., Rademakers, R., Whitwell, J. L., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00447-0 · Cited by 178
Self-citationTemporal order of clinical and biomarker changes in familial frontotemporal dementia
Staffaroni, A. M., Quintana, M., Wendelberger, B., Heuer, H. W., Russell, L. L., Cobigo, Y., Wolf, A., Goh, S.-Y. M., Petrucelli, L., Gendron, T. F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01942-9 · Cited by 140
Self-citationBiomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
Katzeff, J. S., Bright, F., Phan, K., Kril, J. J., Ittner, L. M., Kassiou, M., Hodges, J. R., Piguet, O., Kiernan, M. C., Halliday, G. M., et al. (2022) · Brain · doi:10.1093/brain/awac077 · Cited by 48
The role of neurofilament light in genetic frontotemporal lobar degeneration
Zetterberg, H., Teunissen, C., van Swieten, J., Kuhle, J., Boxer, A., Rohrer, J. D., Mitic, L., Nicholson, A. M., Pearlman, R., McCaughey, S. M., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac310 · Cited by 19
Self-citationBenussi, A., Libri, I., Premi, E., Alberici, A., Cantoni, V., Gadola, Y., Rivolta, J., Pengo, M., Gazzina, S., Calhoun, V. D., et al. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12326 · Cited by 14
Self-citation
Metadata
- Authors
- Panman, J. L., Venkatraghavan, V., van der Ende, E. L., Steketee, R. M. E., Jiskoot, L. C., Poos, J. M., Dopper, E. G. P., Meeter, L. H. H., Donker Kaat, L., Rombouts, S. A. R. B., Vernooij, M. W., Kievit, A. J. A., Premi, E., Cosseddu, M., Bonomi, E., Olives, J., Rohrer, J. D., Sánchez-Valle, R., Borroni, B., Bron, E. E., Van Swieten, J. C., Papma, J. M., & Klein, S.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2021-01-15
- Volume
- 92
- Issue
- 5
- Pages
- 494-501
- ISSN
- 0022-3050 (ISSN-L)
- 1468-330X
- OpenAlex
- W3120209873
- Cited by
- 38
- References
- 15
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- European Reference Network For Rare Neurological Diseases (739510)
- NIHR Rare Disease Translational Research Collaboration (BRC149/NS/MH)
- Stichting Dioraphte (09-02-00)
- The Bluefield Project (n/a)
- Association for Frontotemporal Degeneration (2009)
- MRC UK GENFI (MR/M023664/1)
- ZonMw (733050103, 733050813)
- Fundació Marató de TV3 (20143810)
- Hartstichting (2018B011)
- Horizon 2020 Framework Programme (666992)
- MRC Clinical Scientist Fellowship (MR/M008525/1)
- Alzheimer Nederland (WE.09-2014-4)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016-130-677, HCMI 056-13-018)
- EU Joint Programme - Neurodegenerative Disease Research (733051042)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia. https://app.cochat.ai/papers/10.1136/jnnp-2020-323541
- The paper
- Panman, J. L., Venkatraghavan, V., van der Ende, E. L., Steketee, R. M. E., Jiskoot, L. C., Poos, J. M., Dopper, E. G. P., Meeter, L. H. H., Donker Kaat, L., Rombouts, S. A. R. B., Vernooij, M. W., Kievit, A. J. A., Premi, E., Cosseddu, M., Bonomi, E., Olives, J., Rohrer, J. D., Sánchez-Valle, R., Borroni, B., . . . Klein, S. (2021). Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2020-323541
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.